- Can Zuckerberg duck deposition in Meta privacy class action?

Meta Platforms is appealing to the 9th U.S. Circuit Court to block CEO Mark Zuckerberg's deposition in a privacy class action lawsuit, invoking the "apex doctrine" to argue he lacks unique knowledge regarding allegations of unauthorized health data collection via Meta Pixel. This appeal, following a district court's approval of the deposition, is crucial as it addresses the extent to which top executives can be compelled to testify in high-stakes litigation, potentially setting a significant precedent for corporate legal defense and executive accountability in privacy-related cases given the substantial damages at stake from similar past rulings.

Analysis

Meta Platforms is actively contesting a court order that would compel CEO Mark Zuckerberg to be deposed in a significant privacy class-action lawsuit. The company has petitioned the 9th U.S. Circuit Court of Appeals, invoking the 'apex doctrine' to argue that Zuckerberg lacks unique, first-hand knowledge of the matter and that the request is a litigation tactic for leverage. The lawsuit alleges that Meta's Pixel tracking tool illicitly collected sensitive health information from users via third-party websites, a claim Meta refutes by placing liability on the healthcare providers who implemented the tool. This legal challenge carries substantial weight, as it follows a recent jury verdict in a similar case involving the Flo Health app, where Meta was found to have violated the California Invasion of Privacy Act, exposing the company to potentially massive damages. A lower court has already permitted a limited, three-hour deposition of Zuckerberg, focusing on his role as the final decision-maker for privacy and his connection to a prior FTC consent decree, amplifying the governance and accountability risks. The outcome of this appeal is a critical issue not just for Meta but for the broader tech sector, as it could establish a key precedent for the deposition of high-level executives in numerous pending lawsuits.

Key Decisions for Investors

• Investors should closely monitor the 9th Circuit's ruling on the deposition, as a decision compelling Zuckerberg to testify would represent a significant legal setback and likely increase negative sentiment and stock volatility.
• The established precedent from the Flo Health case verdict indicates a material financial risk; therefore, shareholders should factor in the potential for substantial damages from this class action into their valuation models for META.
• This litigation highlights persistent governance and data privacy risks, and long-term investors should evaluate whether the potential legal liabilities and regulatory scrutiny are adequately priced into the company's shares.